Imbio PHA (4.0.0) vs Stethee Pro 1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio (a subsidiary of 4DMedical)
VS
by M3DICINE

AI Verdict

Imbio PHA is an AI-powered software designed for analyzing CT pulmonary angiogram scans to measure cardiac structures and aid in diagnosing conditions like pulmonary embolism and hypertension. In contrast, Stethee Pro 1 is an AI-enabled wireless digital stethoscope system that captures and analyzes real-time cardiac and respiratory vital signs. While both tools leverage AI in cardiology and pulmonology, Imbio focuses on advanced image interpretation, whereas Stethee Pro 1 provides real-time physiological data acquisition and analysis, making them suitable for different stages and types of diagnostic assessment.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if your primary need is automated, quantitative analysis of cardiac structures from existing CT pulmonary angiogram (CTPA) scans. This tool is ideal for radiologists and cardiologists requiring precise measurements of ventricular and arterial diameters, RV/LV and PA/Ao ratios, to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. It excels in providing rapid, standardized assessments from imaging data.

View Imbio PHA (4.0.0) →

Choose Stethee Pro 1 if…

Choose Stethee Pro 1 if you require a portable, real-time solution for capturing and analyzing cardiac and respiratory vital signs directly from the patient. This system is best suited for clinicians in emergency medicine, remote monitoring, or telemedicine settings who need immediate, AI-assisted auscultation, advanced sound amplification, and secure sharing of physiological data for rapid diagnostic insights. It provides dynamic patient assessment at the point of care.

View Stethee Pro 1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio PHA (4.0.0) Stethee Pro 1
Pricing Unknown $499 usd
Deployment Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). Cloud, Mobile
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Imbio PHA (4.0.0)

Tool A (Imbio PHA) integrates seamlessly into existing radiology workflows, generating annotated DICOM images and PDF reports that are automatically delivered to PACS. This minimizes disruption and learning curve for radiologists, allowing them to use familiar tools. Tool B (Stethee Pro 1) introduces a new physical device with a mobile app and web portal, which, while intuitive and fast (20-second data capture), represents a new interaction paradigm for clinicians.

Clinical Value

Imbio PHA (4.0.0)

Both tools are FDA-cleared and offer significant clinical value. Tool A (Imbio PHA) provides automated, objective, and quantitative measurements from CTPA scans for critical conditions like pulmonary embolism and hypertension, aiding in definitive diagnosis and risk stratification. Tool B (Stethee Pro 1) offers real-time cardiac and respiratory vital sign analysis, which is valuable for immediate assessment, screening, and remote monitoring, but Tool A's focus on precise imaging biomarkers for life-threatening conditions gives it a slight edge in definitive diagnostic impact.

Pricing & Value

Stethee Pro 1

Tool B (Stethee Pro 1) offers transparent pricing with a clear upfront cost for the device ($499) and a subscription model for its web portal, making its value proposition clear and accessible. Tool A (Imbio PHA) requires contacting for pricing, which typically indicates a higher, enterprise-level cost with less upfront transparency, potentially posing a higher barrier to entry for smaller practices or individual users.

Enterprise Readiness

Imbio PHA (4.0.0)

Tool A (Imbio PHA) explicitly supports enterprise-level deployment, including on-premise options, and integrates directly with native DICOM tools and workflows, which are critical for large hospital systems. Its third-party HIPAA certification further enhances its appeal for large organizations. Tool B (Stethee Pro 1) is cloud-based and mobile, which can be integrated, but lacks the explicit enterprise deployment and deep system integration features of Tool A.

Innovation

Stethee Pro 1

Tool B (Stethee Pro 1) demonstrates a higher degree of innovation by transforming a traditional diagnostic tool (stethoscope) into an AI-enabled, connected system with real-time analytics, advanced sound processing, and unique features like automatic geo-location and environmental data tagging. While Tool A (Imbio PHA) innovates by automating complex image analysis, Tool B's approach is more disruptive to an existing clinical practice and offers novel data dimensions.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offered sufficient specific details regarding the quality, availability, or depth of support and documentation for either tool to make a definitive distinction. Both companies provide contact information for support and user manuals are available online, but a head-to-head comparison of their support ecosystems is not possible with the available data.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio PHA (4.0.0) Stethee Pro 1
Name Imbio PHA (4.0.0) Stethee Pro 1
Primary Purpose AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. FDA-cleared, AI-enabled wireless digital stethoscope system providing real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing for enhanced diagnostics and telemedicine.
Company Imbio M3DICINE Pty Ltd.
Primary Data Input CT pulmonary angiogram (CTPA) scans Cardiac and respiratory vital signs (captured by stethoscope)
Key Output/Analysis Automated measurement of right and left ventricle diameters, automated measurement of main pulmonary artery and aorta diameters, calculates RV/LV and PA/Ao ratios, generates annotated DICOM images, provides summary reports in PDF format. Captures cardiac and respiratory vital signs in 20 seconds, measures systole, diastole, heart cycle durations, and respiration rate, real-time visualization of heart (PCG, AIDA Cycle, AIDA Energy) and lung sounds (spectrogram).

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Stethee Pro 1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio PHA (4.0.0) is an AI-powered software that processes existing CT pulmonary angiogram (CTPA) scans to measure cardiac structures. Stethee Pro 1 is an AI-enabled wireless digital stethoscope system that captures real-time cardiac and respiratory vital signs through auscultation.
Imbio PHA (4.0.0) provides automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. Stethee Pro 1 measures systole, diastole, heart cycle durations, and respiration rate, offering real-time visualization of heart (PCG, AIDA Cycle, AIDA Energy) and lung sounds (spectrogram).
Imbio PHA (4.0.0) integrates with native DICOM tools and workflows, generating annotated DICOM images and PDF summary reports that can be sent to PACS. Stethee Pro 1 utilizes a mobile app (iOS and Android) and a HIPAA-compliant Central Web Portal for secure data capture, analysis, recording, playback, and sharing capabilities, and can generate patient vital sign reports for EHR import.
Imbio PHA (4.0.0) is designed to support Cardiology, Pulmonology, and Radiology. Stethee Pro 1 is intended for Cardiology, Emergency Medicine, and Pulmonology.
Both tools are FDA-cleared and claim HIPAA compliance. Imbio PHA (4.0.0) is third-party certified by Compliancy Group. Stethee Pro 1's system claims HIPAA compliance and handles protected health information, implying a Business Associate Agreement (BAA).
AI Tool Finder
AI-powered search. Results may not be comprehensive.